Amarnath Sharma

3.5k total citations
62 papers, 2.8k citations indexed

About

Amarnath Sharma is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Amarnath Sharma has authored 62 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Amarnath Sharma's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Biosimilars and Bioanalytical Methods (9 papers) and Cancer Treatment and Pharmacology (8 papers). Amarnath Sharma is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Biosimilars and Bioanalytical Methods (9 papers) and Cancer Treatment and Pharmacology (8 papers). Amarnath Sharma collaborates with scholars based in United States, Canada and United Kingdom. Amarnath Sharma's co-authors include Robert M. Straubinger, Robert Millham, William J. Jusko, Jesús Gómez-Navarro, Antoni Ribas, Donghua Yin, Mark J. Goldberg, Benito J. Cerimele, Honghui Zhou and James M. Reuben and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Amarnath Sharma

62 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amarnath Sharma United States 27 994 893 605 332 293 62 2.8k
Cody J. Peer United States 33 1.5k 1.5× 1.8k 2.0× 626 1.0× 85 0.3× 187 0.6× 156 4.0k
Joanne Lysaght Ireland 30 1.2k 1.2× 888 1.0× 858 1.4× 169 0.5× 103 0.4× 95 3.3k
Robert A. Parise United States 30 1.0k 1.0× 1.4k 1.6× 202 0.3× 141 0.4× 104 0.4× 100 3.0k
Yahiya Y. Syed New Zealand 36 1.0k 1.0× 1.3k 1.5× 420 0.7× 101 0.3× 148 0.5× 107 3.8k
Akinobu Hamada Japan 36 1.6k 1.6× 1.2k 1.3× 417 0.7× 74 0.2× 102 0.3× 178 3.7k
John J. Kavanagh United States 39 1.4k 1.4× 1.5k 1.7× 502 0.8× 134 0.4× 83 0.3× 121 4.7k
Yi Luo China 32 854 0.9× 1.8k 2.0× 587 1.0× 89 0.3× 247 0.8× 149 4.3k
Lionel D. Lewis United States 36 1.7k 1.7× 1.4k 1.6× 595 1.0× 72 0.2× 190 0.6× 167 4.2k
Michael W. DeGregorio United States 31 1.1k 1.1× 759 0.8× 188 0.3× 66 0.2× 526 1.8× 99 3.1k
John J. Rinehart United States 27 988 1.0× 1.0k 1.1× 568 0.9× 125 0.4× 108 0.4× 67 2.9k

Countries citing papers authored by Amarnath Sharma

Since Specialization
Citations

This map shows the geographic impact of Amarnath Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amarnath Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amarnath Sharma more than expected).

Fields of papers citing papers by Amarnath Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amarnath Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amarnath Sharma. The network helps show where Amarnath Sharma may publish in the future.

Co-authorship network of co-authors of Amarnath Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Amarnath Sharma. A scholar is included among the top collaborators of Amarnath Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amarnath Sharma. Amarnath Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Girgis, Suzette, Shun Xin Wang Lin, Kodandaram Pillarisetti, et al.. (2022). Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma. Targeted Oncology. 17(4). 433–439. 10 indexed citations
2.
Hu, Chuanpu, Honghui Zhou, & Amarnath Sharma. (2020). Facilitating Longitudinal Exposure-Response Modeling of a Composite Endpoint Using the Joint Modeling of Sparsely and Frequently Collected Subcomponents. The AAPS Journal. 22(4). 79–79. 4 indexed citations
3.
Hu, Chuanpu, Honghui Zhou, & Amarnath Sharma. (2020). Applying Beta Distribution in Analyzing Bounded Outcome Score Data. The AAPS Journal. 22(3). 61–61. 9 indexed citations
4.
Hu, Chuanpu, Honghui Zhou, & Amarnath Sharma. (2020). Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score Data. The AAPS Journal. 22(5). 95–95. 3 indexed citations
5.
Zhuang, Yanli, Di Chen, Amarnath Sharma, & Zhenhua Xu. (2018). Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective. The AAPS Journal. 20(6). 109–109. 5 indexed citations
6.
Hu, Chuanpu, Omoniyi J. Adedokun, Liping Zhang, Amarnath Sharma, & Honghui Zhou. (2018). Modeling near-continuous clinical endpoint as categorical: application to longitudinal exposure–response modeling of Mayo scores for golimumab in patients with ulcerative colitis. Journal of Pharmacokinetics and Pharmacodynamics. 45(6). 803–816. 9 indexed citations
7.
Hu, Chuanpu, B. Randazzo, Amarnath Sharma, & Honghui Zhou. (2017). Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patients. Journal of Pharmacokinetics and Pharmacodynamics. 44(5). 437–448. 19 indexed citations
8.
Liu, Ping, et al.. (2007). Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects. The Journal of Clinical Pharmacology. 48(1). 73–84. 54 indexed citations
9.
Chandra, Richa, Ping Liu, Jeanne D. Breen, et al.. (2007). Clinical Pharmacokinetics and Gastrointestinal Tolerability of a Novel Extended-Release Microsphere Formulation of Azithromycin. Clinical Pharmacokinetics. 46(3). 247–259. 25 indexed citations
10.
Guo, Feng, Stephen P. Letrent, & Amarnath Sharma. (2007). Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors. Cancer Chemotherapy and Pharmacology. 60(6). 799–809. 11 indexed citations
11.
Toler, Steven M., Dennis A. Noe, & Amarnath Sharma. (2006). Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurgical FOCUS. 21(6). 1–4. 52 indexed citations
12.
Pitot, Henry C., Alex A. Adjei, Joel M. Reid, et al.. (2005). A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 58(2). 165–172. 23 indexed citations
13.
Xie, Rujia, Catherine Hong, Toufigh Gordi, et al.. (2005). CYP3A and P‐Glycoprotein Activity Induction With St. John's Wort in Healthy Volunteers From 6 Ethnic Populations. The Journal of Clinical Pharmacology. 45(3). 352–356. 45 indexed citations
14.
Zhou, Qingyu, et al.. (2005). Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemotherapy and Pharmacology. 56(6). 569–577. 50 indexed citations
15.
Sharma, Amarnath, Mark J. Goldberg, & Benito J. Cerimele. (2000). Pharmacokinetics and Safety of Duloxetine, a Dual‐Serotonin and Norepinephrine Reuptake Inhibitor. The Journal of Clinical Pharmacology. 40(2). 161–167. 120 indexed citations
16.
Dimitroff, Charles J., Wayne D. Klohs, Amarnath Sharma, et al.. (1999). Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy. Investigational New Drugs. 17(2). 121–135. 71 indexed citations
17.
Sharma, Amarnath, et al.. (1999). Modeling Interactions between Adrenal Suppression and T-Helper Lymphocyte Trafficking during Multiple Dosing of Methylprednisolone. Journal of Pharmacokinetics and Biopharmaceutics. 27(6). 559–575. 20 indexed citations
18.
Sharma, Amarnath, E. Mayhew, Lois E. Bolcsak, et al.. (1997). Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. International Journal of Cancer. 71(1). 103–107. 112 indexed citations
19.
Sharma, Amarnath, Walter D. Conway, & Robert M. Straubinger. (1994). Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma. Journal of Chromatography B Biomedical Sciences and Applications. 655(2). 315–319. 52 indexed citations
20.
Sharma, Amarnath, et al.. (1993). Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.. Pharmaceutical Research. 10(10). 1434–1441. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026